EUVIMEDEUVIMED entdecken
Open Access

Prevalence of HIV Drug Resistance Mutations among Treatment-Naive People Living with HIV in a Tertiary Care Center in India

Shweta Srivastva, Jaya Chakravarty, Anurag Kumar Kushwaha

The American Journal of Tropical Medicine and Hygiene · 03.04.2024 · 110 (4) · 713-718

DOI: 10.4269/ajtmh.23-0026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 03.04.2024. Verfasst von Shweta Srivastva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Anti-HIV Agents, Alkynes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

India has the third-largest number of people living with HIV (PLHIV) in the world. A national program provides free access to standard uniform antiretroviral therapy. However, the program is not monitored by comprehensive drug resistance surveys. The aim of this study was to determine the prevalence of HIV drug resistance mutations (DRMs) among treatment-naive PLHIV in a large antiretroviral treatment center of the national program. This cross-sectional study was done in 2017 and involved 200 consecutive treatment-naive PLHIV. A target fragment of 1,306 bp in the reverse transcriptase and protease regions was amplified. Identification of mutations and drug resistance interpretation was done by HIV Genotypic Resistance Interpretation and International Antiviral Society-USA list. Sequencing was successful in 177 samples. The majority (98.8%; 175/177) belonged to subtype C. Nineteen of 177 patients (10.7%; 95% CI: 6.2%–15.3%) had at least one major DRM. The prevalence of non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations was 10.2% (18/177). The most frequent mutations were E138A/K, A98G, K103N, V179D, and K101H/E. The prevalence of nucleoside reverse transcriptase inhibitor (NRTI) mutations was 1.1% (2/177). None of the samples had major protease inhibitor resistance mutations. The prevalence of NNRTI mutations in this study was >10%, crossing the threshold recommended by the WHO to change the NNRTI-based first-line regimen to non–NNRTI based. In 2021, the national program replaced efavirenz with dolutegravir in the first-line regimen of tenofovir, lamivudine, and efavirenz. As the majority (64%) of PLHIV in India are accessing free ART from the national program, this study highlights the need for regular nationally representative drug resistance surveys for optimizing antiretroviral regimens in the program.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsAnti-HIV AgentsAlkynesCyclopropanesHumansReverse Transcriptase InhibitorsPrevalenceTertiary Care CentersCross-Sectional StudiesBenzoxazinesAnti-Retroviral AgentsMutationDrug Resistance, Viral

Substanzen

Reverse Transcriptase InhibitorsefavirenzBenzoxazinesAnti-Retroviral AgentsAnti-HIV AgentsAlkynesCyclopropanes

Autor:innen und Institutionen

  • Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Zitieren

APA

Srivastva, S., Chakravarty, J., & Kushwaha, A. K. (2024). Prevalence of HIV Drug Resistance Mutations among Treatment-Naive People Living with HIV in a Tertiary Care Center in India. The American Journal of Tropical Medicine and Hygiene, 110(4), 713-718. https://doi.org/10.4269/ajtmh.23-0026

Vancouver

Srivastva S, Chakravarty J, Kushwaha AK. Prevalence of HIV Drug Resistance Mutations among Treatment-Naive People Living with HIV in a Tertiary Care Center in India. The American Journal of Tropical Medicine and Hygiene. 2024;110(4):713-718. doi:10.4269/ajtmh.23-0026

BibTeX
@article{Srivastva2024,
  author = {Srivastva, Shweta and Chakravarty, Jaya and Kushwaha, Anurag Kumar},
  title = {Prevalence of HIV Drug Resistance Mutations among Treatment-Naive People Living with HIV in a Tertiary Care Center in India},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2024},
  volume = {110},
  number = {4},
  pages = {713--718},
  doi = {10.4269/ajtmh.23-0026}
}
Kostenlos starten →